{"altmetric_id":2353652,"selected_quotes":["Upcoming trends in myeloma therapy","New video - discussing upcoming trends in #myeloma therapy @myelomabeacon"],"citation":{"altmetric_jid":"ecancerorg","first_seen_on":"2014-05-15T14:52:30+00:00","issns":[],"journal":"ecancer","last_mentioned_on":1400491949,"links":["http:\/\/ecancer.org\/video\/2844\/upcoming-trends-in-myeloma-therapy.php"],"title":"Upcoming trends in myeloma therapy. Upcoming trends inmyeloma therapy. ecancer.tv - Essential viewing foroncologists","type":"article","uri":"http:\/\/ecancer.org\/video\/2844\/upcoming-trends-in-myeloma-therapy.php"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":3764723,"mean":4.995321371617,"rank":2850256,"this_scored_higher_than_pct":19,"this_scored_higher_than":749974,"rank_type":"exact","sample_size":3764723,"percentile":19},"similar_age_3m":{"total_number_of_other_articles":96340,"mean":7.2121584421516,"rank":72689,"this_scored_higher_than_pct":20,"this_scored_higher_than":19621,"rank_type":"exact","sample_size":96340,"percentile":20},"this_journal":{"total_number_of_other_articles":5183,"mean":2.5187664994211,"rank":3702,"this_scored_higher_than_pct":23,"this_scored_higher_than":1207,"rank_type":"exact","sample_size":5183,"percentile":23},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":1,"Practitioners (doctors, other healthcare professionals)":1}}},"geo":{"twitter":{"GB":1}}},"counts":{"total":{"posts_count":3},"twitter":{"unique_users_count":2,"unique_users":["ecancer_espanol","ecancer"],"posts_count":3}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ecancer_espanol\/status\/467237278537252864","license":"datasift","citation_ids":[2353652],"posted_on":"2014-05-16T09:37:02+00:00","author":{"name":"ecancer en espa\u00f1ol","url":"http:\/\/www.ecancer.org\/spanish","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000103922296\/c5a7dd69f291e06c34e863daf5f4c779_normal.png","description":"Somos el canal l\u00edder en Oncolog\u00eda comprometido a mejorar la comunicaci\u00f3n del C\u00e1ncer. \u00a1Visita nuestra prestigiosa revista m\u00e9dica!","id_on_source":"ecancer_espanol","tweeter_id":"1530437286","geo":{"lt":null,"ln":null},"followers":1506},"tweet_id":"467237278537252864"},{"url":"http:\/\/twitter.com\/ecancer_espanol\/status\/468323295927222272","license":"datasift","citation_ids":[2353652],"posted_on":"2014-05-19T09:32:29+00:00","author":{"name":"ecancer en espa\u00f1ol","url":"http:\/\/www.ecancer.org\/spanish","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000103922296\/c5a7dd69f291e06c34e863daf5f4c779_normal.png","description":"Somos el canal l\u00edder en Oncolog\u00eda comprometido a mejorar la comunicaci\u00f3n del C\u00e1ncer. \u00a1Visita nuestra prestigiosa revista m\u00e9dica!","id_on_source":"ecancer_espanol","tweeter_id":"1530437286","geo":{"lt":null,"ln":null},"followers":1506},"tweet_id":"468323295927222272"},{"url":"http:\/\/twitter.com\/ecancer\/status\/466954171632340993","license":"datasift","citation_ids":[2353652],"posted_on":"2014-05-15T14:52:04+00:00","author":{"name":"ecancer","url":"http:\/\/www.ecancer.org","image":"https:\/\/pbs.twimg.com\/profile_images\/449503716438056960\/SqsDdkL0_normal.png","description":"ecancer is a not for profit, open access, independent medical education platform, committed to improving cancer communication & education.","id_on_source":"ecancer","tweeter_id":"19975787","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":12882},"tweet_id":"466954171632340993"}]}}